RECENT POSTS

30

May, 2019

BIOMARK’S ABSTRACT FOR 2019 ASCO ONLINE PUBLICATION

By: | Tags: | Comments: 0

Follow-up evaluation of outliers with elevated spermine-spermidine acetyltransferase-1 activity. Sub-category: Circulating Biomarkers Category: Developmental Therapeutics and Tumor Biology (Nonimmuno) Meeting: 2019 ASCO Annual Meeting Abstract No: e14536 Citation: J Clin Oncol 37, 2019 (suppl; abstr e14536) Author(s): Andrew W. Maksymiuk,…

READ MORE
Cancer risk in families

26

Mar, 2019

Cancer risk in families

By: | Tags: | Comments: 0

If you have family members with cancer, you may wonder if you are at risk of developing it too (if it “runs in the family”). Sometimes a gene mutation that can cause cancer is passed on to you by your parents (inherited). Cancers caused by inherited gene mutations are called inherited cancers. And sometimes cancer happens more often in family members who share the same habits, live in the same…

READ MORE
Glioblastoma Multiforme (GBM)

26

Mar, 2019

About Glioblastoma (GBM)

By: | Tags: | Comments: 0

Overview Tumour Group: Gliomas WHO Grade: Grade IV Prevalence/Incidence: The incidence of glioblastoma multiforme (GBM) is 2 to 3 per 100,000 people in the United States and Europe. GBM accounts for 12 to 15% of all intracranial tumours and…

READ MORE
Lung Cancer Screening in Real World Has High False-Positive Rate

26

Mar, 2019

Lung Cancer Screening in Real World Has High False-Positive Rate

By: | Tags: | Comments: 0

By Kelly YoungEdited by: David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD A pair of studies in JAMA Internal Medicine illustrate the difficulties of implementing lung cancer screening. In the first, eight Veterans Health Administration medical centers identified and screened patients using low-dose computed tomography (LDCT). Over 2100 patients who were eligible for screening based on smoking history and other factors completed LDCT. Overall, 60% had nodules, but just 1.5%…

READ MORE